FDC Limited has informed the Exchange regarding a press release dated October 29, 2020, titled "Launch of stronger versions of Favipiravir Drug (PiFLU and Favenza) meant to treat mild to moderate cases of Covid 19.".
FDC Limited has informed the Exchange regarding a press release dated October 29, 2020, titled "Launch of stronger versions of Favipiravir Drug (PiFLU and Favenza) meant to treat mild to moderate cases of Covid 19.".